Evidence map›Paper›PMID 25816313›Full record

ArticlePloS one2015

α7 Nicotinic acetylcholine receptor-specific antibody induces inflammation and amyloid β42 accumulation in the mouse brain to impair memory.

Olena Lykhmus, Larysa Voytenko, Lyudmyla Koval, Sergiy Mykhalskiy, Victor Kholin, Kateryna Peschana, Marios Zouridakis, Socrates Tzartos, Sergiy Komisarenko, Maryna Skok

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Changing Functional Signatures of Microglia along the Axis of Brain Aging.International journal of molecular sciences · 2021
    Review
  16. Review
  17. Inhibitory Effects of Raw-ExtractMolecules (Basel, Switzerland) · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Olena LykhmusPalladin Institute of Biochemistry, Kyiv, Ukraine.
Larysa VoytenkoBogomoletz Institute of Physiology, Kyiv, Ukraine.
Lyudmyla KovalPalladin Institute of Biochemistry, Kyiv, Ukraine.
Sergiy MykhalskiyChebotaryov Institute of Gerontology, Kyiv, Ukraine.
Victor KholinChebotaryov Institute of Gerontology, Kyiv, Ukraine.
Kateryna PeschanaChebotaryov Institute of Gerontology, Kyiv, Ukraine.
Marios ZouridakisHellenic Pasteur Institute, Athens, Greece.
Socrates TzartosHellenic Pasteur Institute, Athens, Greece.
Sergiy KomisarenkoPalladin Institute of Biochemistry, Kyiv, Ukraine.
Maryna SkokPalladin Institute of Biochemistry, Kyiv, Ukraine.
Palladin Institute of Biochemistry · UAD.F. Chebotarev Institute of Gerontology · UAPasteur Hellenic Institute · GRBogomoletz Institute of Physiology · UA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nicotinic acetylcholine receptors (nAChRs) expressed in the brain are involved in regulating cognitive functions, as well as inflammatory reactions. Their density is decreased upon Alzheimer disease accompanied by accumulation of β-amyloid (Aβ42), memory deficit and neuroinflammation. Previously we found that α7 nAChR-specific antibody induced pro-inflammatory interleukin-6 production in U373 glioblastoma cells and that such antibodies were present in the blood of humans. We raised a hypothesis that α7 nAChR-specific antibody can cause neuroinflammation when penetrating the brain. To test this, C57Bl/6 mice were either immunized with extracellular domain of α7 nAChR subunit α7(1-208) or injected with bacterial lipopolysaccharide (LPS) for 5 months. We studied their behavior and the presence of α3, α4, α7, β2 and β4 nAChR subunits, Aβ40 and Aβ42 and activated astrocytes in the brain by sandwich ELISA and confocal microscopy. It was found that either LPS injections or immunizations with α7(1-208) resulted in region-specific decrease of α7 and α4β2 and increase of α3β4 nAChRs, accumulation of Aβ42 and activated astrocytes in the brain of mice and worsening of their episodic memory. Intravenously transferred α7 nAChR-specific-antibodies penetrated the brain parenchyma of mice pre-injected with LPS. Our data demonstrate that (1) neuroinflammation is sufficient to provoke the decrease of α7 and α4β2 nAChRs, Aβ42 accumulation and memory impairment in mice and (2) α7(1-208) nAChR-specific antibodies can cause inflammation within the brain resulting in the symptoms typical for Alzheimer disease.

Indexed as

alpha7 Nicotinic Acetylcholine ReceptorAlzheimer DiseaseAmyloid beta-PeptidesAnimalsAntibodiesBrainHumansInflammationInterleukin-6LipopolysaccharidesMemory DisordersMiceNeuronsReceptors, Nicotinicalpha7 Nicotinic Acetylcholine ReceptorAmyloid beta-PeptidesAntibodiesInterleukin-6Lipopolysaccharidesnicotinic receptor alpha3beta4nicotinic receptor alpha4beta2Receptors, Nicotinic

Identifiers

PMID25816313
PMCPMC4376778
OpenAlexW2070484780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.